Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Author(s): Santoveña A, Llabrés M, Fariña JB
Issue: Sep/Oct 2010 - Supporting Quality Pharmaceutical Compounding World Wide
View All Articles in Issue
Page(s): 430-435
Download in electronic PDF format for $65
Abstract: There were two objectives of this study, one of which was to ensure that different 1-mg/mL hydrocortisone oral suspensions that were prepared as compounded preparations in four accredited laboratories using the same standard operating procedure were in accordance with the general quality controls of these disperse systems and the specific requirements of the European Pharmacopeia, the Royal Spanish Pharmacopeia, and the United States Pharmacopeia. The other objective was to confirm the shelf-life of 90 days that was established for this type of compounded preparation. All the suspensions were in accordance with the organoleptic controls and with the theoretically calculated volume per unit of the preparation, but the amount of active ingredient per volume of the preparations were smaller than the theoretically expected. This result was attributed to the standard operating procedure because no significative differences between laboratories and days were detected, in which an excess of active ingredient is necessary to include in the process to ensure the declared dose. By high-performance liquid chromatography, it was possible to confirm the 90 days of stability of the drug at 5°C.
Related Keywords:
A. Santoveña, PhD, M. Llabrés, J.B. Fariña, hydrocortisone oral suspension, formulation, stability
Related Categories:
FORMULATIONS, PEER-REVIEWED, STABILITIES, COMPATIBILITIES, QUALITY CONTROL, ALLERGY/IMMUNOLOGY/INFLAMMATION
Printer-Friendly Version
Related Articles from IJPC |
Title/Author
(Click for Abstract / Details / Purchase) |
Issue/Page
View/Buy |
Quality Control and Physical and Chemical Stability of Hydrocortisone Oral Suspension: An Interlaboratory Study
Santoveña A, Llabrés M, Fariña JB
|
Sep/Oct 2010
Pg. 430-435
|
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Kader Cyndy, Morris Tommy C, Graves Richard A
|
Sep/Oct 2021
Pg. 431-439
|
Physical and Chemical Stability of Budesonide Mucoadhesive Oral Suspensions (MucoLox)
Ip Kendice, Carvalho Maria, Shan Ashley, Banov Daniel
|
Jul/Aug 2017
Pg. 322-329
|
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension
Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H
|
Jan/Feb 2018
Pg. 66-75
|
Physicochemical and Microbiological Stabilities of Hydrocortisone in InOrpha Suspending Agent Studied Under Various Condition
Bourget Philippe, Amin Alexandre, Vidal Fabrice, Pieyre Manon, Dosso El Ourmar, Beauvais Raphaelle, Loeuillet Richard
|
Sep/Oct 2014
Pg. 427-431
|
Formulation and Accelerated Stability Studies for an Extemporaneous Suspension of Amiodarone Hydrochloride
Alexander Kenneth S, Thyangarajapuram N
|
Sep/Oct 2003
Pg. 389-393
|
Physicochemical Stability of the Extemporaneous Ibuprofen Oral Suspension in "Wagner" Base
Spennacchio Antonio, Lopedota Angela, la Forgia Flavia, Fontana Sergio, Franco Massimo, Denora Nunzio
|
Jan/Feb 2023
Pg. 72-77
|
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents
Gupta Vishnu D
|
May/Jun 2007
Pg. 259-261
|
Investigation of the Physical, Chemical, and Microbiological Stability of Oral Solutions Compounded with Herbals
Khokhlova Kateryna O, Zdoryk Oleksandr A
|
May/Jun 2018
Pg. 240-246
|
Hydrocortisone 2-mg/mL in Oral Mix Suspension
Allen Loyd V Jr
|
Jul/Aug 2021
Pg. 325
|
Stability of Extemporaneously Prepared Hydroxycarbamide Oral Suspensions
Kabiche Djamila, Balde Issa-Bella, Majoul Elyes, Kabiche Sofiane, Bourguignon Elodie, Fontan Jean-Eudes, Cisternino Salvatore, Schlatter Joel
|
Mar/Apr 2017
Pg. 160-163
|
Stability of Extemporaneous Oral Tramadol, Fluoxetine, and Doxycycline Suspensions in SyrSpend SF pH4
Espana B, Joseph-Tornabène F, Jaquet Cécile, Perrot S, Prouillac C
|
Jul/Aug 2020
Pg. 327-336
|
Chemical Stability of Hydrocortisone in Humco Simple Syrup and Ora-Sweet Vehicle
Gupta Vishnu D
|
Jan/Feb 2010
Pg. 76-77
|
Stability Issues for Compounding Extemporaneously Prepared Oral Formulations for Pediatric Patients
Schotik Debora
|
Jan/Feb 2001
Pg. 9-12
|
Stability of Spironolactone Oral Suspension in PCCA Base, SuspendIt
Graves Richard, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Jul/Aug 2017
Pg. 334-338
|
Stability of Levothyroxine, Doxycycline, Hydrocortisone, and Pravastatin in Liquid Dosage Forms Stored at Two Temperatures
Nahata Milap C
|
Sep/Oct 2015
Pg. 428-431
|
Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt
Pramar Yashoda V, Mandal Tarun K, Bostanian Levon A, Le Giang, Morris Tommy C, Graves Richard A
|
Mar/Apr 2021
Pg. 169-175
|
Formulation, Physical Stability, and the Clinical Effectiveness of Extemporaneous Ivermectin Oral Solution
Zaid Abdel-Naser, Zaaror Yara Abu, Qaddumi Aiman, Ratrout Ala, Ahmad Ayda, Hamad Emad, Kittana Naim
|
Nov/Dec 2021
Pg. 523-527
|
Physicochemical Stability of an Oral Suspension of Trimethoprim 20 mg/mL in Combination with Sulfadiazine 200 mg/mL in PCCA Base SuspendIt
Graves Richard A, Phan Kelly V, Bostanian Levon A, Mandal Tarun K, Pramar Yashoda V
|
Sep/Oct 2017
Pg. 430-435
|
Preparation and Stability Evaluation of Extemporaneous Oral Suspension of Valsartan Using Commercially Available Tablets
Zaid Abdel Naser, Assali Mohyeddin, Qaddomi Aiman, Ghanem Mashhour, Zaaror Yara Abu
|
Mar/Apr 2014
Pg. 169-174
|